These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Lesion detectability and quantitative recovery with FDG-PET. Links JM Eur J Nucl Med; 1999 Jun; 26(6):681-2. PubMed ID: 10428608 [No Abstract] [Full Text] [Related]
3. The future of positron emission tomography in oncology depends on interactive basic, nuclear and clinical research. Buell U; Cremerius U; Zimny M Eur J Nucl Med; 1997 Oct; 24(10):1330. PubMed ID: 9432468 [No Abstract] [Full Text] [Related]
4. [Whole body positron emission tomography (PET) with (18F)-fluorodeoxyglucose]. Grupo PET de la SEMN Rev Esp Med Nucl; 2002 Apr; 21(2):128-30. PubMed ID: 11879625 [No Abstract] [Full Text] [Related]
5. PET scanning moves into community hospitals. Kritz FL J Nucl Med; 1999 Nov; 40(11):11N-12N. PubMed ID: 10565767 [No Abstract] [Full Text] [Related]
7. Positron emission tomography: background, possibilities and perspectives in neuroscience. Paans AM Acta Neurol Belg; 1997 Sep; 97(3):150-3. PubMed ID: 9345585 [TBL] [Abstract][Full Text] [Related]
8. Positron-emitting radiopharmaceuticals: how safe are they? Silberstein EB Cancer Biother Radiopharm; 2001 Feb; 16(1):13-5. PubMed ID: 11279793 [No Abstract] [Full Text] [Related]
9. [Rapid increase of the use of PET in cancer investigation--but Sweden lags behind]. Wollmer P; Valind S; Landoni C; Fazio F Ugeskr Laeger; 2000 Jul; 162(27):3846-8. PubMed ID: 10920697 [TBL] [Abstract][Full Text] [Related]
10. The incremental value of diagnostic tests. Wagner HN J Nucl Med; 1997 Feb; 38(2):241-2. PubMed ID: 9025745 [No Abstract] [Full Text] [Related]
11. New 18F-radiopharmaceuticals. Stöcklin G Nuklearmedizin; 1990 Mar; 29(2):80. PubMed ID: 2339087 [No Abstract] [Full Text] [Related]
12. Isotopic labeling with short-lived radionuclides represents the future for clinical PET imaging. For the proposition. Harkness B Med Phys; 2002 Dec; 29(12):2897-8. PubMed ID: 12512725 [No Abstract] [Full Text] [Related]
13. [Cerebral positron emission tomography with F18-fluorodeoxyglucose]. Grupo PET de la SEMN. Rev Esp Med Nucl; 2002 Feb; 21(1):38-40. PubMed ID: 11821002 [No Abstract] [Full Text] [Related]
14. A brief history of positron emission tomography (PET). Wagner HN Semin Nucl Med; 1998 Jul; 28(3):213-20. PubMed ID: 9704363 [TBL] [Abstract][Full Text] [Related]
15. New indications give PET a lift after struggle over regulatory and reimbursement issues. Conti PS; Keppler J Diagn Imaging (San Franc); 2000 Jan; 22(1):40-7. PubMed ID: 10848425 [No Abstract] [Full Text] [Related]
16. Clinical PET in the UK: dangers of missing an opportunity. O'Doherty MJ Nucl Med Commun; 2001 Jul; 22(7):737-9. PubMed ID: 11453044 [No Abstract] [Full Text] [Related]
17. HCFA approves Medicare coverage of PET scans. Cave L J Natl Cancer Inst; 2001 Feb; 93(3):177. PubMed ID: 11158185 [No Abstract] [Full Text] [Related]